Supply chain rules not as bad as feared, say German companies
This article was originally published in Scrip
The 15th amendment to Germany’s pharmaceutical law, AMG 15, voted through by the Bundestag in a late night sitting on June 18th, was not as bad as the local industry had feared regarding regulation of the supply chain.
You may also be interested in...
The national regulator is to undergo a review in 2021 as the UK begins life as a former EU member, presenting opportunities to be seized.
RSNA is the next major global medtech event to be run under a virtual format this fall. Under COVID-19, the major medtechs are finding different ways to demonstrate value, as Royal Philips explains.
The RSNA is the next global medtech exhibition and conference event to be run under a virtual format this fall.